10/02/2025
5:29 PM | Cocrystal Pharma (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SCHEDULE 13D/A | |
09/29/2025
3:58 PM | Cocrystal Pharma (Filer)
| Form 424B3 | |
09/25/2025
11:15 PM | Cocrystal Pharma (Filer)
| Form EFFECT | |
09/19/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/15/2025
3:35 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2025
7:26 AM | Cocrystal Pharma (Filer)
| Form 424B5 | |
09/12/2025
4:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2025
4:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2025
4:18 PM | Cocrystal Pharma (Filer)
| Form 424B3 | |
08/14/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
7:01 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for COCP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cocrystal Pharma and its competitors with MarketBeat's FREE daily newsletter. |
08/05/2025
7:31 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
2:15 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form DEF 14A | |
05/05/2025
3:35 PM | Cocrystal Pharma (Filer)
| Form DEFA14A | |
04/25/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form PRE 14A | |
04/24/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
2:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
8:10 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Japour Anthony J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Martin James Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Lee Sam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Rubin Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
Kornberg Roger D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
4:02 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
